August 19, 2009

BIOGEN IDEC: Expects Trial on Mass. DOR’s Tax Assessment in 2010

COMPANIES: Biogen Idec Inc
Subscribe

Biogen Idec Inc. disclosed in its latest quarterly report on Form 10-Q filed with the U.S. Securities and Exchange Commission that it anticipates the trial on the Massachusetts Department of Revenue’s US$38.9 million tax assessment against its wholly owned subsidiary,…

TO CONTINUE READING,LOGIN or
TOPICS: Drugs/Pharmaceuticals | Drugstores | Earnings | Health Care | Legal Issues, Litigation | Loans & Financing | Medical Supplies | SEC-Qtrly, Annual Reports | Securities & Exch Comm, US | Supplementary Medicine
LOCATIONS: Massachusetts | United States